Related Experiment Video
Updated: Jun 14, 2026
09:29
Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy
Published on: May 4, 2016
Parkinson disease: a role for autophagy?
1Department of Pharmacology, Emory University School of Medicine, Atlanta, Georgia 30322-3090, USA.
Summary
Autophagy, a cellular degradation process, is increasingly linked to neurodegenerative diseases. Studies show Parkinson disease factors disrupt autophagy, suggesting its dysregulation is key to PD pathogenesis.
Area of Science:
- Cellular Biology
- Neuroscience
- Molecular Biology
Background:
- Autophagy is a fundamental cellular process involving lysosomal degradation of intracellular components.
- Initially recognized as a response to nutrient deprivation, autophagy's role extends to various human disorders, notably neurodegenerative diseases.
Purpose of the Study:
- To investigate the connection between etiological factors of Parkinson disease (PD) and the autophagic process.
- To determine if dysregulation of autophagy contributes to the pathogenesis of PD.
Main Methods:
- Review of experimental results from genetic studies.
- Analysis of cellular studies.
- Examination of toxicological studies in various model systems.
Main Results:
- Experimental data indicate that numerous factors associated with Parkinson disease can interfere with autophagy.
- These perturbations of the autophagic process have been observed across diverse model systems.
Conclusions:
- Emerging evidence strongly supports a critical role for autophagy dysregulation in the pathological mechanisms of Parkinson disease.
- Targeting or understanding the autophagic pathway may offer new therapeutic avenues for PD.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
01:27Autophagy
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...